Zevra Denmark A/S: Financial statements 2024
CVR: 43259326
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Zevra Denmark A/S (CVR 43259326) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 70,973,000 and a net result of DKK -132,114,000 compared with DKK -20,506,000 the year before. The profit margin was -186.1%. Equity in the 2024 report amounted to DKK -159,627,000. The company had 4 employees in the financial year.
- Revenue
- DKK 70,973,000
- Gross Profit
- DKK -1,728,000
- Profit/Loss
- DKK -132,114,000
- Equity
- DKK -159,627,000
- Total Assets
- DKK 178,169,000
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 71M | -1.7M | -132.1M | -159.6M | 4 |
| 2023 | - | -12.5M | -20.5M | -27.5M | 6 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Zevra Denmark A/S has published its annual report for 2023. Gross profit came to DKK -12,548,000, and the net result was DKK -20,506,000.
As of March 25, 2024, Neil McFarlane has joined the board of directors of Zevra Denmark A/S.
As of March 25, 2024, Travis Clark Mickle has left the board of directors of Zevra Denmark A/S.
About Zevra Denmark A/S
Zevra Denmark A/S is a Danish company of the type Aktieselskab based in Frederiksberg, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named KemPharm Denmark A/S. The management consists of Timothy Sangiovanni. The board consists of Rahsaan Waleed Thompson (chair), Justin Andrew Renz, Thomas Weitemeyer and Timothy Sangiovanni. The company is owned by Zevra Therapeutics, Inc.. The company has 4 employees (2026). In 2025, the company reported revenue of DKK 123,335,000 and a net result of DKK 334,468,000 compared with DKK -132,114,000 the year before. Equity in the 2025 report amounted to DKK 174,841,000.